|
Predictors of microsatellite status identified by Support Vector Machine and PAM algorithms. |
||||||||
| Probe |
Symbol |
Average expression |
p-value |
SVM* strength |
PAM* score |
|||
| Gene name |
MSS |
MSI-H |
MSI-H |
MSS |
||||
|
|
||||||||
| hsa-mir-223-prec |
miR-223 |
0.97 |
1.84 |
4.69E-02 |
- |
0.4929 |
-0.3429 |
|
| hsa-mir-155-prec |
miR-155 (BIC) |
0.97 |
1.29 |
2.34E-02 |
- |
0.4439 |
-0.3088 |
|
| AL137343 |
FAM84A |
family with sequence similarity 84, member A |
1.51 |
0.45 |
1.07E-02 |
- |
-0.0208 |
0.0145 |
| NM_004183 |
VMD2 |
vitelliform macular dystrophy 2 |
2.09 |
0.38 |
8.73E-03 |
- |
-0.1832 |
0.1274 |
| NM_006113 |
VAV3 |
vav 3 oncogene |
1.62 |
0.47 |
5.98E-03 |
13.96 |
-0.0533 |
0.0371 |
| NM_005953 |
MT2A |
metallothionein 2A |
0.57 |
1.92 |
5.93E-03 |
16.34 |
0.8995 |
-0.6258 |
| AK026372 |
KIAA1718 |
1.27 |
0.72 |
5.09E-03 |
16.02 |
- |
- |
|
| hsa-mir-191-prec |
miR-191 |
1.28 |
1.00 |
4.74E-03 |
- |
0.0377 |
-0.0263 |
|
| NM_017726 |
PPP1R14D |
protein phosphatase 1, regulatory (inhibitor) subunit 14D |
1.31 |
0.52 |
3.88E-03 |
14.58 |
- |
- |
| NM_003212 |
TDGF1 |
teratocarcinoma-derived growth factor 1 |
1.49 |
0.76 |
3.37E-03 |
16.49 |
- |
- |
| AF273051 |
CCDC68 |
coiled-coil domain containing 68 |
2.21 |
0.84 |
2.49E-03 |
15.87 |
-0.0541 |
0.0376 |
| NM_016328 |
GTF2IRD1 |
GTF2I repeat domain containing 1 |
1.49 |
0.87 |
2.13E-03 |
13.13 |
- |
- |
| NM_001657 |
AREG |
amphiregulin |
2.10 |
0.69 |
1.04E-03 |
- |
-0.0725 |
0.0504 |
| AB033045 |
KIAA1219 |
hypothetical protein LOC57148 |
1.33 |
0.83 |
8.11E-04 |
15.87 |
- |
- |
| hsa-mir-032-precNo2 |
miR-032 |
1.17 |
0.91 |
6.48E-04 |
14.02 |
0.0732 |
-0.0509 |
|
| NM_004485 |
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4 |
1.46 |
0.81 |
6.47E-04 |
16.49 |
- |
- |
| NM_018267 |
H2AFJ |
H2A histone family, member J |
1.43 |
0.92 |
6.47E-04 |
13.96 |
- |
- |
| AK000276 |
NKD1 |
naked cuticle homolog 1 |
2.47 |
0.77 |
4.55E-04 |
17.48 |
-0.1542 |
0.1072 |
| NM_003878 |
GGH |
gamma-glutamyl hydrolase |
2.10 |
0.61 |
7.97E-05 |
15.87 |
-0.2232 |
0.1553 |
| AK025215 |
C13ORF18 |
chromosome 13 open reading frame 18 |
2.41 |
0.66 |
4.40E-05 |
16.49 |
-0.3093 |
0.2152 |
| NM_017763 |
RNF43 |
ring finger protein 43 |
2.10 |
0.57 |
2.91E-05 |
17.48 |
-0.2886 |
0.2008 |
| NM_004693 |
K6HF |
cytokeratin type II |
1.24 |
0.80 |
2.91E-05 |
14.6 |
- |
- |
| NM_002657 |
PLAGL2 |
pleiomorphic adenoma gene-like 2 |
1.37 |
0.76 |
2.91E-05 |
19.32 |
- |
- |
| hsa-mir-025-prec |
miR-025 |
1.52 |
0.84 |
2.14E-05 |
17.48 |
- |
- |
|
| hsa-mir-092-prec-13=092-1No2 |
miR-092-1 |
1.50 |
0.65 |
1.87E-05 |
17.48 |
- |
- |
|
| hsa-mir-092-prec-X=092-2 |
miR-092-2 |
1.60 |
0.64 |
1.87E-05 |
14.43 |
- |
- |
|
| hsa-mir-093-prec-7.1=093-1 |
miR-093-1 |
1.23 |
0.9 |
1.87E-05 |
- |
0.0084 |
-0.0058 |
|
|
* SVM: Support Vector Machine; PAM: Prediction Analysis of Microarray | ||||||||
Lanza et al. Molecular Cancer 2007 6:54 doi:10.1186/1476-4598-6-54 |
||||||||